This inventor holds 2 USPTO granted patents and 2 EPO patents. Top assignees: Trinity College Dublin, University College Dublin. Active years: 2016-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 141 
2 out of 121 
Years Active: 2016-2017
Title: Claire Kilty: Innovator in Anti-Angiogenic Compounds
Introduction
Claire Kilty is a prominent inventor based in Dublin, Ireland. She has made significant contributions to the field of medicinal chemistry, particularly in the development of anti-angiogenic compounds. With a total of 2 patents, her work focuses on addressing diseases related to angiogenesis.
Latest Patents
Claire Kilty's latest patents include innovative compounds such as (E)-2-(2-Quinolin-2-yl-propenyl)-phenol and 2-Quinolin-2-yl-ylethynyl-phenol. These compounds and their salts are recognized for their potential as medicaments, especially in the treatment of angiogenesis-related diseases or disorders. Her research emphasizes the importance of these compounds in advancing therapeutic options.
Career Highlights
Throughout her career, Claire has been associated with esteemed institutions such as Trinity College Dublin and University College Dublin. Her work in these academic environments has allowed her to explore and develop her innovative ideas further.
Collaborations
Claire has collaborated with notable colleagues, including Andrew Douglas Baxter and Breandan Kennedy. These partnerships have contributed to her research and the successful development of her patented compounds.
Conclusion
Claire Kilty stands out as a dedicated inventor whose work in anti-angiogenic compounds has the potential to impact medical treatments significantly. Her contributions to the field reflect her commitment to innovation and research excellence.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile